This inventor holds 8 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: Alexion Pharmaceuticals, Inc.. Active years: 2008-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2015
Title: The Innovations of Dayang Wu
Introduction
Dayang Wu, based in Cheshire, CT, is a prominent inventor recognized for his contributions in the field of biotechnology. With a remarkable portfolio of 8 patents, Wu has made significant strides in the development of therapeutic innovations targeting CD200 positive cells.
Latest Patents
Among his most recent work, Wu holds patents for "Antibodies to OX-2/CD200 and uses thereof." This innovative application outlines methods and compositions for modulating and/or depleting CD200 positive cells, showcasing the potential for new therapeutic strategies in medical treatments.
Career Highlights
Wu currently works with Alexion Pharmaceuticals, Inc., where he has further honed his expertise in biopharmaceutical development. His work is characterized by a commitment to advancing therapeutic approaches that could have meaningful impacts on patient care.
Collaborations
Throughout his career, Wu has collaborated with fellow innovators such as Russell P. Rother and Katherine S. Bowdish. These partnerships exemplify the collaborative spirit of scientific research, enhancing the potential for groundbreaking discoveries in their field.
Conclusion
Dayang Wu's inventive contributions and ongoing research underscore the vital role of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical therapies that may improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile